All Drugs Associated with Chronic kidney disease (Page 2)
756 drugs have been associated with Chronic kidney disease in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| DAPAGLIFLOZIN | 190 | 6 | 62 | 25 |
| TELMISARTAN | 186 | 5 | 67 | 3 |
| ETANERCEPT | 180 | 12 | 33 | 4 |
| RUXOLITINIB | 170 | 40 | 93 | 11 |
| TORSEMIDE | 170 | 30 | 142 | 15 |
| CISPLATIN | 162 | 12 | 57 | 20 |
| RIVAROXABAN | 162 | 39 | 122 | 7 |
| DARBEPOETIN ALFA | 161 | 31 | 105 | 3 |
| EVEROLIMUS | 156 | 29 | 94 | 5 |
| SITAGLIPTIN | 155 | 74 | 106 | 35 |
| ECULIZUMAB | 152 | 18 | 52 | 4 |
| DICLOFENAC | 151 | 29 | 32 | 5 |
| SEMAGLUTIDE | 151 | 1 | 41 | 10 |
| CLOZAPINE | 147 | 34 | 90 | 41 |
| IBRUTINIB | 147 | 19 | 57 | 2 |
| CARBOPLATIN | 142 | 9 | 66 | 3 |
| CLOPIDOGREL BISULFATE | 142 | 41 | 113 | 2 |
| FENTANYL | 133 | 15 | 13 | 0 |
| AZATHIOPRINE | 128 | 15 | 44 | 9 |
| VENLAFAXINE | 128 | 0 | 5 | 1 |
| BUDESONIDE | 127 | 0 | 7 | 1 |
| BUPROPION | 125 | 0 | 3 | 0 |
| EMPAGLIFLOZIN | 124 | 4 | 60 | 5 |
| TOCILIZUMAB | 124 | 6 | 21 | 2 |
| BEVACIZUMAB | 123 | 9 | 50 | 3 |
| VINCRISTINE | 123 | 4 | 63 | 49 |
| DAPAGLIFLOZIN PROPANEDIOL | 120 | 6 | 29 | 7 |
| ERGOCALCIFEROL | 120 | 0 | 12 | 0 |
| HYDROXYCHLOROQUINE | 120 | 1 | 22 | 2 |
| METOPROLOL | 120 | 2 | 44 | 6 |
| NIVOLUMAB | 120 | 28 | 77 | 18 |
| METHYLPREDNISOLONE | 119 | 24 | 57 | 23 |
| CARVEDILOL | 117 | 8 | 96 | 2 |
| SUMATRIPTAN | 116 | 0 | 2 | 0 |
| AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE | 114 | 6 | 6 | 0 |
| LAMIVUDINE | 114 | 4 | 32 | 0 |
| MESALAMINE | 114 | 1 | 6 | 0 |
| ACETAMINOPHEN | 110 | 26 | 47 | 16 |
| IMATINIB | 110 | 27 | 23 | 1 |
| PALBOCICLIB | 110 | 10 | 35 | 19 |
| ABATACEPT | 106 | 1 | 12 | 0 |
| ALENDRONATE | 106 | 9 | 96 | 1 |
| ETOPOSIDE | 106 | 5 | 32 | 5 |
| INSULIN HUMAN | 106 | 4 | 34 | 2 |
| MACITENTAN | 106 | 39 | 90 | 11 |
| PEMBROLIZUMAB | 106 | 11 | 54 | 10 |
| ACEBUTOLOL | 105 | 0 | 0 | 0 |
| BOTULINUM TOXIN TYPE A | 103 | 0 | 0 | 0 |
| LISINOPRIL | 103 | 5 | 50 | 8 |
| NAPROXEN | 103 | 0 | 10 | 1 |